Keyphrases
Parkinson's Disease
79%
Leucine-rich Repeat Kinase 2 (LRRK2)
54%
Mutation Carriers
18%
G2019S mutation
18%
Parkinson Patients
17%
Ashkenazi Jews
17%
Patients with Parkinson's Disease
17%
Non-carriers
16%
LRRK2 mutation
14%
Parkinson's Disease Risk
12%
Non-manifesting Carriers
11%
G2019S
9%
Idiopathic Parkinson's Disease
8%
LRRK2 Gene
8%
Disease Phenotype
8%
Functional Magnetic Resonance Imaging
7%
GBA1
7%
GBA mutations
6%
Executive Function
6%
GBA Gene
6%
Disease-related
6%
Ashkenazi
6%
Genotype
5%
Unified Parkinson's Disease Rating Scale (UPDRS)
5%
Dementia with Lewy Bodies
5%
Creutzfeldt-Jakob Disease
5%
Neuroscience
Parkinson's Disease
100%
Leucine Rich Repeat Kinase 2
16%
Glucosylceramidase
9%
Functional Magnetic Resonance Imaging
9%
Magnetic Resonance Imaging
6%
Functional Connectivity
5%
Stereotypic Movement Disorder
5%
Executive Function
5%
Dementia with Lewy Body
5%
